ImmuVen
About:
ImmuVen develops drugs to treat infectious diseases, cancer, and autoimmune disorders.
Website: http://www.immuven.com
Top Investors: National Institutes of Health, Serra Ventures
Description:
ImmuVenis is a biotechnology company with novel technology to discover and develop new biotherapeutics to treat infectious disease, cancer and autoimmune disorders
Total Funding Amount:
$1.93M
Headquarters Location:
Champaign, Illinois, United States
Founded Date:
2007-01-01
Contact Email:
quinn(AT)immuven.com
Founders:
David Kranz, Patrick Schlievert
Number of Employees:
1-10
Last Funding Date:
2012-05-01
IPO Status:
Private
Industries:
© 2025 bioDAO.ai